Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 1
Submit an article Journal homepage
74
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Remarkable donor-derived T cell lymphocytosis before engraftment of a bone marrow transplant for acute lymphoblastic leukemia

Yurie NagaiDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan;
,
Shokichi TsukamotoDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan; Correspondence[email protected]
,
Yutaro HinoDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan;
,
Yusuke IsshikiDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan;
,
Miki YamazakiDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan;
,
Shintaro IzumiDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan;
,
Tatsuzo MishinaDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan;
,
Nagisa Oshima-HasegawaDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan;
,
Shio MitsukawaDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan; ;Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan;
,
Yusuke TakedaDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan;
,
Naoya MimuraDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan; ;Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan;
,
Chikako OhwadaDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan;
,
Masahiro TakeuchiDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan;
,
Tohru IsekiDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan; ;Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan;
,
Chiaki NakasekoDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan; ;Department of Hematology, International University of Health and Welfare School of Medicine, Narita, Japan
&
Emiko SakaidaDepartment of Hematology, Chiba University Hospital, Chiba, Japan; ;Blood and Marrow Transplant Center, Chiba University Hospital, Chiba, Japan;
show all
Pages 221-224 | Received 19 Jun 2019, Accepted 20 Aug 2019, Published online: 05 Sep 2019

References

  • Spitzer TR. Engraftment syndrome: double-edged sword of hematopoietic cell transplants. Bone Marrow Transplant. 2015;50(4):469–475.
  • Kishi Y, Kami M, Miyakoshi S, et al. Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. Transplantation. 2005;80(1):34–40.
  • Kanda J, Kaynar L, Kanda Y, et al. Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. Bone Marrow Transplant. 2013;48(7):926–931.
  • Patel KJ, Rice RD, Hawke R, et al. Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease. Biol Blood Marrow Transplant. 2010;16(3):435–440.
  • Lee YH, Lim YJ, Kim JY, et al. Pre-engraftment syndrome in hematopoietic stem cell transplantation. J Korean Med Sci. 2008;23(1):98–103.
  • Frangoul H, Wang L, Harrell FE, Jr, et al. Preengraftment syndrome after unrelated cord blood transplant is a strong predictor of acute and chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2009;15(11):1485–1488.
  • Hong KT, Kang HJ, Kim NH, et al. Peri-engraftment syndrome in allogeneic hematopoietic SCT. Bone Marrow Transplant. 2013;48(4):523–528.
  • Park M, Lee SH, Lee YH, et al. Pre-engraftment syndrome after unrelated cord blood transplantation: a predictor of engraftment and acute graft-versus-host disease. Biol Blood Marrow Transplant. 2013;19(4):640–646.
  • Konuma T, Kohara C, Watanabe E, et al. Cytokine profiles of pre-engraftment syndrome after single-unit cord blood transplantation for adult patients. Biol Blood Marrow Transplant. 2017;23(11):1932–1938.
  • Politikos I, Boussiotis VA. The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation. Blood. 2014;124(22):3201–3211.
  • Williams KM, Gress RE. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation. Best Pract Res Clin Haematol. 2008;21:579–596.
  • Solano C, Gimenez E, Albert E, et al. Pre-engraftment cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes. Bone Marrow Transplant. 2018;54(1):90–98.
  • Suessmuth Y, Mukherjee R, Watkins B, et al. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire. Blood. 2015;125(25):3835–3850.
  • Kanda Y, Yamashita T, Mori T, et al. A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT. Bone Marrow Transplant. 2010;45(8):1325–1332.
  • Gentile G, Picardi A, Capobianchi A, et al. A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation. BMC Infect Dis. 2006;6(1):167.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.